Memo
From: Deborah Porterfield, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation (ASPE)
Date: March 27, 2024
Subject: OMB Control Number 0990-0421, Expires 2/28/2027
ASPE requests approval for non-substantive changes to site visit data collection for the Best Practices for COVID-19 Vaccination and Testing study, based on pilot interview experience. We request these changes to improve the quality of the data collected by our contractor.
Summary of change: The contractor will no longer request 15 minutes of planning time from the primary staff person at each program selected for site visits. They will now request recommendations for additional program and partner staff respondents within the 60-minute interview time. This reduces burden for up to 57 lead program respondents by a total of 14.25 hours and $637 in burden costs.
Justification for change: Eliminating the extra 15 minutes is expected to support response rates because it is easier for respondents to commit to one hour than to more than one hour. Higher response rates will increase the quality of the data collected.
Summary of change: Instead of providing a $25 Visa gift card to community representative respondents who complete 30-minute interviews, we will increase this amount to $50. We will also provide $100 Visa gift cards to program and partner staff who complete 60-minute interviews.
Justification for change: The new payment amounts appropriately compensate respondents for their time and expertise. These amounts are also expected to boost response rates because they are more consistent with current standards for respondent compensation. Higher response rates will increase the quality of the data collected.
Summary of change: We made two types of changes to outreach materials. First, we made minor updates in the text to offer interview scheduling options, to offer payments for all program respondents, and, for initial outreach emails, to CC (carbon copy) the person who recommended the potential respondent. We also added three new outreach email templates, one for the planning call outreach, and one each for reaching out to and following up with partner respondents.
Justification for change: Updates to existing materials reflect changes to our processes to improve response rates, which will increase the quality of the data collected. New outreach email templates are customized to meet the needs of specific respondent types, also with the goal of improving response rates and improving the quality of the data collected.
Pilot interviews revealed the need to refine the flow of the interviews, clarify the intention of some questions, and improve the face validity of the questions. The revisions will support interviewers’ ability to collect rich data and identify nuances and novel findings. Table 1 (see next page) provides details on changes to instruments and justification for changes.
Table 1: Summary of changes to interview guides and justification
Original interview guide text
|
Changes to interview guide text |
Summary of justification for change and benefit to the information collection |
Changes to instructions to interviewers |
||
All interview guide instructions: You do not need to read the content in parentheses; use that content as needed to help respondents if they ask for clarification. |
All interview guide instructions: Collect detailed information on each topic. Use the questions and probes under each topic to help respondents generate details and information relevant to our project’s research questions. |
|
Program and partner introductory talking points: I have you scheduled for [75 minutes for program leaders; 60 minutes for program staff and partners]. Are you available to talk for that amount of time? |
Program and partner introductory talking points: I have you scheduled for 60 minutes. Are you available to talk for that amount of time? |
|
Changes to clarify interview questions |
||
Public health leader Q2b; program and partner Q3: How did you change those efforts to make them more effective over time?
Program and partner Q2c: [If not already answered] How has [program] worked to improve COVID-19 testing or vaccination confidence? What about access? Awareness? Uptake or use?
|
Public health leader Q2b; program and partner Q2c: [If unanswered, and for each effort] When did this effort take place? (early in the pandemic before vaccines were available, after adult vaccines became available, after child vaccines became available, later)
Program and partner Q2c-d:
|
|
Public health leader Q5 (similar changes made to program and partner Q14) What policies have supported improvements in COVID-19 vaccination and testing for people at disproportionate risk?
Did any policies present challenges? Why? |
Public health leader Q5 (similar changes made to program and partner Q13) What policies have supported improvements in COVID-19 vaccination and testing for people at disproportionate risk? By policy, we mean a law, regulation, procedure, administrative action, incentive, or voluntary practice of government and other institutions. Policy is frequently reflected in resource allocation.
Did any policies present challenges? Why? [Ask for names of policies or examples of policies in action so we can dig up specifics in analysis if needed] |
|
Program and partner Q7: What are the views of the community on how well [program] works?
|
Program and partner Q7: What are the views of the people or communities the [program] intended to serve on how well [program] works?
What actions have you taken based on ideas from the people or communities [program] intended to serve, if any? |
|
N/A |
Public health leader guide instructions: We’d like you to think about your perspective on the [state/tribal organization] rather than talk in detail about specific programs or strategies you worked on. |
|
Changes to questions to focus respondents’ answers |
||
Public health leader guide Q6: What have been the roles of your partners in efforts to improving COVID-19 testing or vaccination? By partners, we mean organizations that contributed to the success of programs that work to improve COVID-19 testing and vaccinations, such as by helping design, plan, implement, or contribute resources.
Program and partner Q13a: Who were the different partners? What were their roles? |
Public health leader guide Q6: Now I want to talk about partners [site] may have worked with. By partners, we mean organizations that contributed to the success of [site] programs that work to improve COVID-19 testing and vaccinations, such as by helping design, plan, implement, or contribute resources.
Who were your most important or effective partners during the COVID-19 pandemic, and why? vaccination?
Program and partner Q12a: Who were [the program’s] most important or effective partners, and why?
|
|
Public health leader Q13a: Have you combined resources from different funding sources for these activities? If so, how? |
Public health leader Q13a: Have you combined resources from different funding sources for these activities? If so, how did that go? |
|
Program and partner Q1: What is/was your role in relation to [program]? How long have you had/did you have that role? |
Program and partner Q1: I’d like to focus our discussion on [program’s] efforts related to [COVID-19 testing/vaccination.] What was your role in relation to COVID-19 [testing or vaccination] at [program] during the pandemic? How long have you did you have that role? |
|
Community representative Q5: Are you aware of if [program] asked community members for ideas on how to design the program or make it better? [If yes] How did they do that? (Probe on community advisory boards, or similar entities) |
Community representative Q5: Can you recall any aspects of [program] that didn’t work that well for [community identified in Q1], and that you think could have been, or could be, improved to better meet the needs of the community? |
|
Changes to the specific focus of the question |
||
Program and partner Q18: [For program leaders only, if program leader mentioned a data source in response to Q7a] We are interested in looking at the data that programs collected to measure effectiveness, to help us understand the different ways that programs collected and used data for COVID-19 services. Previously, you mentioned [describe data from Q7a]. Would you be willing to share the data to inform part of our study? We can provide way to securely transfer the data and we would never share it with anyone outside of our research team without your permission. Alternatively, if you have any report or write up of your program data, are you able to share that with us? |
Program and partner Q17: [For program leaders only, if program leader mentioned a data source in response to Q5b] We are interested in looking at any analyses or assessments you might have conducted to understand how well [program] worked. Previously, you mentioned [describe data from Q5b]. Would you be willing to share any results or analyses to inform part of our study, if those are available in the form of reports or presentations?
|
|
Community representative Q1: I’ll start by asking you about yourself. How would you describe your connection to [community]?
|
Community representative Q1: I’ll start by asking you about yourself. How would you describe your connection to the [program] and the [community/communities] that it intended to serve?
|
|
Deleted questions to save time in interviews |
||
Public health leader Q6d: Which of these were new partnerships for your COVID-19 testing/vaccination work? Why were new partnerships needed? |
None |
|
Public health leader Q18: How did you come up with this definition of success? |
None |
|
Public health leader Q18b: Which activities do you think were most successful or effective at improving COVID-19 services for specific populations? |
None |
|
Public health leader question 18c: [If relevant] Did the activity improve awareness of COVID-19 services? Confidence in the COVID-19 vaccine? Access to COVID-19 service? Use of COVID-19 services? |
None |
|
Program and partner Q2a: [If not already answered] Did [program] focus on COVID-19 testing, vaccination, or both? If so, how?
|
None |
|
Program and partner Q8: From your perspective, how has operating [program] gone? (Use Q10-11 to follow up on their response to this general question). |
None |
|
Program and partner Q10a: [If unanswered] What about the planning process helped the program succeed? (Examples include identifying milestones, defining measures of success, clarifying roles and responsibilities, seeking community input, tailoring the program to be culturally relevant and align with community’s values.) |
None |
|
Program Q10 c-d:
|
None |
|
Program and partner Q11: What was [program]’s experience with these resources? |
None |
|
Program and partner Q3b: How have you prioritized what needs or barriers to services to address in [program]? |
None |
|
Community representative Q8: Are you aware of any other efforts to help people in the community stay up to date on routine vaccines during the pandemic, such as education about why that was important or any other support for getting routine vaccines? |
N/A |
|
Community representative Q3f: Did [program] change how often people got tested? How? |
N/A |
|
Changes to the wording or ordering of questions to improve flow and efficiency of interviews |
||
Public health leader Q19: How has [state/tribal organization] assessed the effectiveness of the COVID-19 testing activities it provides? What about COVID-19 vaccination activities?
|
Public health leader Q18: What were your [state’s/tribal organization’s] specific goals related to COVID-19 testing? What were your goals related to COVID-19 vaccination? [Interviewers: probe to understand if programs intended to improve awareness, confidence, access, or use of testing/vaccines in general]
|
|
Program and partner Q4: How have you designed communication efforts to address the values and beliefs of the people [program] intends to serve?
Program and partner Q11: What resources were needed to operate [program]? (Examples of resources include funding, service site, staff, technology, cold storage, community members or leaders)
|
Program and partner Q4: How did you design [program] to meet the needs of [populations of focus]? For example, making [program] culturally relevant, designing it to address specific barriers such as communication preferences and transportation availability. This could also include adapting services to meet the needs of specific groups, such as extending hours, co-locating with other social services, offering translation, etc.
|
|
Program and partner Q12: I’m also curious about the cost of [program]. Could you give me a ballpark estimate of how much it costs to run [program], overall or by year? What are the biggest expenses for [program]? |
Program and partner Q11: I’m also curious about the cost of [program]. What were/are the biggest expenses for [program]?
|
|
Program and partner Q17: How will COVID-19 [services] that [program] provides change in the future?
What resources will you need to continue? Probe to understand barriers and facilitators to continuing [program] in the long term. |
Program and partner Q16: Do you plan to continue offering the COVID-19 [services] that [program] provides in the future? [If yes to Q18] What resources will you need to continue? [Probe to understand barriers and facilitators to continuing [program] in the long term.] |
|
New questions added |
||
N/A |
Program and partner Q19: To wrap up, I’d like you to think back on our conversation and your experience with the pandemic. What do you think is most important for me to get on the record to help other programs met the needs of people who are medically or socially at disproportionate risk of adverse outcomes, should another pandemic arise? |
|
N/A
|
Program and partner Q20: [Read for all program respondents] Finally, would you be willing for [this program/organization] to be identified in a vignette or short profile about your efforts in our reports? If not, that’s completely OK. |
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | Mathematica Memo |
Subject | memo |
Author | Kate Bradley |
File Modified | 0000-00-00 |
File Created | 2024-07-24 |